APO Research
Talk to an analyst

APO RESEARCH · REPORT

Single-target MET TKIs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Single-target MET TKIs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025185 pages

Choose your research edition.

Industry ResearchSingle-target MET TKIs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Single-target MET TKIs Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Single-target MET TKIs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Single-target MET TKIs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Single-target MET TKIs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Single-target MET TKIs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Single-target MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Single-target MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Single-target MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Single-target MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Single-target MET TKIs include CSPC Pharmaceutical, Asymchem, Shanghai Hutchison Pharmaceuticals, WuXi STA, Haihe Biopharma, Avistone Pharmaceuticals Biotechnology, Novartis and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Single-target MET TKIs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Single-target MET TKIs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Single-target MET TKIs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Single-target MET TKIs market size, projected growth trends, production technologies, key applications, and end-use industries.

Single-target MET TKIs Segment by Company

CSPC Pharmaceutical

Asymchem

Shanghai Hutchison Pharmaceuticals

WuXi STA

Haihe Biopharma

Avistone Pharmaceuticals Biotechnology

Novartis

Merck

Single-target MET TKIs Segment by Type

Tepotinib

Savolitinib

Capmatinib

Glumetinib

Vebreltinib

Other

Single-target MET TKIs Segment by Application

Retail Pharmacies

Hospital and Clinic

Other

Single-target MET TKIs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Single-target MET TKIs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Single-target MET TKIs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Single-target MET TKIs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Single-target MET TKIs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Single-target MET TKIs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Single-target MET TKIs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Single-target MET TKIs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Single-target MET TKIs Industry Trends Table 2. Single-target MET TKIs Industry Drivers Table 3. Single-target MET TKIs Industry Opportunities and Challenges Table 4. Single-target MET TKIs Industry Restraints Table 5. Global Single-target MET TKIs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Single-target MET TKIs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Single-target MET TKIs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Single-target MET TKIs Sales Market Share by Manufacturers Table 9. Global Single-target MET TKIs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Single-target MET TKIs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Single-target MET TKIs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Single-target MET TKIs Manufacturers, Product Type & Application Table 13. Global Single-target MET TKIs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Single-target MET TKIs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tepotinib Table 17. Major Manufacturers of Savolitinib Table 18. Major Manufacturers of Capmatinib Table 19. Major Manufacturers of Glumetinib Table 20. Major Manufacturers of Vebreltinib Table 21. Major Manufacturers of Other Table 22. Global Single-target MET TKIs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Single-target MET TKIs Sales by Type (2021-2026) & (K Units) Table 24. Global Single-target MET TKIs Sales by Type (2027-2032) & (K Units) Table 25. Global Single-target MET TKIs Sales Market Share by Type (2021-2026) Table 26. Global Single-target MET TKIs Sales Market Share by Type (2027-2032) Table 27. Global Single-target MET TKIs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 28. Global Single-target MET TKIs Revenue by Type (2021-2026) & (K Units) Table 29. Global Single-target MET TKIs Revenue by Type (2027-2032) & (K Units) Table 30. Global Single-target MET TKIs Revenue Market Share by Type (2021-2026) Table 31. Global Single-target MET TKIs Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Retail Pharmacies Table 33. Major Manufacturers of Hospital and Clinic Table 34. Major Manufacturers of Other Table 35. Global Single-target MET TKIs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Single-target MET TKIs Sales by Application (2021-2026) & (K Units) Table 37. Global Single-target MET TKIs Sales by Application (2027-2032) & (K Units) Table 38. Global Single-target MET TKIs Sales Market Share by Application (2021-2026) Table 39. Global Single-target MET TKIs Sales Market Share by Application (2027-2032) Table 40. Global Single-target MET TKIs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global Single-target MET TKIs Revenue by Application (2021-2026) & (K Units) Table 42. Global Single-target MET TKIs Revenue by Application (2027-2032) & (K Units) Table 43. Global Single-target MET TKIs Revenue Market Share by Application (2021-2026) Table 44. Global Single-target MET TKIs Revenue Market Share by Application (2027-2032) Table 45. Global Single-target MET TKIs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Single-target MET TKIs Sales by Region (2021-2026) & (K Units) Table 47. Global Single-target MET TKIs Sales Market Share by Region (2021-2026) Table 48. Global Single-target MET TKIs Sales Forecasted by Region (2027-2032) & (K Units) Table 49. Global Single-target MET TKIs Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Single-target MET TKIs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. North America Single-target MET TKIs Sales by Country (2021-2026) & (K Units) Table 52. North America Single-target MET TKIs Sales by Country (2027-2032) & (K Units) Table 53. Europe Single-target MET TKIs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Europe Single-target MET TKIs Sales by Country (2021-2026) & (K Units) Table 55. Europe Single-target MET TKIs Sales by Country (2027-2032) & (K Units) Table 56. Asia Pacific Single-target MET TKIs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Asia Pacific Single-target MET TKIs Sales by Country (2021-2026) & (K Units) Table 58. Asia Pacific Single-target MET TKIs Sales by Country (2027-2032) & (K Units) Table 59. South America, Middle East and Africa Single-target MET TKIs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. South America, Middle East and Africa Single-target MET TKIs Sales by Country (2021-2026) & (K Units) Table 61. South America, Middle East and Africa Single-target MET TKIs Sales by Country (2027-2032) & (K Units) Table 62. Global Single-target MET TKIs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Single-target MET TKIs Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Single-target MET TKIs Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Single-target MET TKIs Revenue Market Share by Region (2021-2026) Table 66. Global Single-target MET TKIs Revenue Market Share by Region (2027-2032) Table 67. CSPC Pharmaceutical Company Information Table 68. CSPC Pharmaceutical Business Overview Table 69. CSPC Pharmaceutical Single-target MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. CSPC Pharmaceutical Single-target MET TKIs Product Portfolio Table 71. CSPC Pharmaceutical Recent Development Table 72. Asymchem Company Information Table 73. Asymchem Business Overview Table 74. Asymchem Single-target MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Asymchem Single-target MET TKIs Product Portfolio Table 76. Asymchem Recent Development Table 77. Shanghai Hutchison Pharmaceuticals Company Information Table 78. Shanghai Hutchison Pharmaceuticals Business Overview Table 79. Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Product Portfolio Table 81. Shanghai Hutchison Pharmaceuticals Recent Development Table 82. WuXi STA Company Information Table 83. WuXi STA Business Overview Table 84. WuXi STA Single-target MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. WuXi STA Single-target MET TKIs Product Portfolio Table 86. WuXi STA Recent Development Table 87. Haihe Biopharma Company Information Table 88. Haihe Biopharma Business Overview Table 89. Haihe Biopharma Single-target MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Haihe Biopharma Single-target MET TKIs Product Portfolio Table 91. Haihe Biopharma Recent Development Table 92. Avistone Pharmaceuticals Biotechnology Company Information Table 93. Avistone Pharmaceuticals Biotechnology Business Overview Table 94. Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Product Portfolio Table 96. Avistone Pharmaceuticals Biotechnology Recent Development Table 97. Novartis Company Information Table 98. Novartis Business Overview Table 99. Novartis Single-target MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Novartis Single-target MET TKIs Product Portfolio Table 101. Novartis Recent Development Table 102. Merck Company Information Table 103. Merck Business Overview Table 104. Merck Single-target MET TKIs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Merck Single-target MET TKIs Product Portfolio Table 106. Merck Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Single-target MET TKIs Distributors List Table 110. Single-target MET TKIs Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Single-target MET TKIs Product Image Figure 2. Global Single-target MET TKIs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Single-target MET TKIs Market Size (2021-2032) & (US$ Million) Figure 4. Global Single-target MET TKIs Sales (2021-2032) & (K Units) Figure 5. Global Single-target MET TKIs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Single-target MET TKIs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tepotinib Image Figure 9. Savolitinib Image Figure 10. Capmatinib Image Figure 11. Glumetinib Image Figure 12. Vebreltinib Image Figure 13. Other Image Figure 14. Global Single-target MET TKIs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Single-target MET TKIs Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Single-target MET TKIs Sales Market Share by Type (2021-2032) Figure 17. Global Single-target MET TKIs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Single-target MET TKIs Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Single-target MET TKIs Revenue Market Share by Type (2021-2032) Figure 20. Retail Pharmacies Image Figure 21. Hospital and Clinic Image Figure 22. Other Image Figure 23. Global Single-target MET TKIs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Single-target MET TKIs Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Single-target MET TKIs Sales Market Share by Application (2021-2032) Figure 26. Global Single-target MET TKIs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Single-target MET TKIs Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Single-target MET TKIs Revenue Market Share by Application (2021-2032) Figure 29. North America Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. North America Single-target MET TKIs Sales Market Share by Country (2021-2032) Figure 31. U.S. Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Canada Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Mexico Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Single-target MET TKIs Sales Market Share by Country (2021-2032) Figure 36. Germany Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. France Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. U.K. Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Italy Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Netherlands Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Single-target MET TKIs Sales Market Share by Country (2021-2032) Figure 43. China Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Japan Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South Korea Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Southeast Asia Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. India Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Australia Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Single-target MET TKIs Sales Market Share by Country (2021-2032) Figure 51. Brazil Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South Africa Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Saudi Arabia Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Turkey Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Argentina Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. UAE Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Egypt Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Chile Single-target MET TKIs Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Global Single-target MET TKIs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Single-target MET TKIs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Single-target MET TKIs Revenue (2021-2032) & (US$ Million) Figure 62. North America Single-target MET TKIs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Single-target MET TKIs Revenue (2021-2032) & (US$ Million) Figure 64. Europe Single-target MET TKIs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Single-target MET TKIs Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Single-target MET TKIs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Single-target MET TKIs Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Single-target MET TKIs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Single-target MET TKIs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Single-target MET TKIs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Tepotinib
  • Savolitinib
  • Capmatinib
  • Glumetinib
  • Vebreltinib
  • Other
Applications
  • Retail Pharmacies
  • Hospital and Clinic
  • Other
Companies covered
  • CSPC Pharmaceutical
  • Asymchem
  • Shanghai Hutchison Pharmaceuticals
  • WuXi STA
  • Haihe Biopharma
  • Avistone Pharmaceuticals Biotechnology
  • Novartis
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Single-target MET TKIs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Single-target MET TKIs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Single-target MET TKIs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Single-target MET TKIs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Single-target MET TKIs Market Dynamics
  1. 2.1 Single-target MET TKIs Industry Trends
  2. 2.2 Single-target MET TKIs Industry Drivers
  3. 2.3 Single-target MET TKIs Industry Opportunities and Challenges
  4. 2.4 Single-target MET TKIs Industry Restraints
3 Single-target MET TKIs Market by Manufacturers
  1. 3.1 Global Single-target MET TKIs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Single-target MET TKIs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Single-target MET TKIs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Single-target MET TKIs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Single-target MET TKIs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Single-target MET TKIs Manufacturers, Product Type & Application
  7. 3.7 Global Single-target MET TKIs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Single-target MET TKIs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Single-target MET TKIs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Single-target MET TKIs Tier 1, Tier 2, and Tier 3
4 Single-target MET TKIs Market by Type
  1. 4.1 Single-target MET TKIs Type Introduction
  2. 4.1.1 Tepotinib
  3. 4.1.2 Savolitinib
  4. 4.1.3 Capmatinib
  5. 4.1.4 Glumetinib
  6. 4.1.5 Vebreltinib
  7. 4.1.6 Other
  8. 4.2 Global Single-target MET TKIs Sales by Type
  9. 4.2.1 Global Single-target MET TKIs Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Single-target MET TKIs Sales by Type (2021-2032)
  11. 4.2.3 Global Single-target MET TKIs Sales Market Share by Type (2021-2032)
  12. 4.3 Global Single-target MET TKIs Revenue by Type
  13. 4.3.1 Global Single-target MET TKIs Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Single-target MET TKIs Revenue by Type (2021-2032)
  15. 4.3.3 Global Single-target MET TKIs Revenue Market Share by Type (2021-2032)
5 Single-target MET TKIs Market by Application
  1. 5.1 Single-target MET TKIs Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Hospital and Clinic
  4. 5.1.3 Other
  5. 5.2 Global Single-target MET TKIs Sales by Application
  6. 5.2.1 Global Single-target MET TKIs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Single-target MET TKIs Sales by Application (2021-2032)
  8. 5.2.3 Global Single-target MET TKIs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Single-target MET TKIs Revenue by Application
  10. 5.3.1 Global Single-target MET TKIs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Single-target MET TKIs Revenue by Application (2021-2032)
  12. 5.3.3 Global Single-target MET TKIs Revenue Market Share by Application (2021-2032)
6 Global Single-target MET TKIs Sales by Region
  1. 6.1 Global Single-target MET TKIs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Single-target MET TKIs Sales by Region (2021-2032)
  3. 6.2.1 Global Single-target MET TKIs Sales by Region (2021-2026)
  4. 6.2.2 Global Single-target MET TKIs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Single-target MET TKIs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Single-target MET TKIs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Single-target MET TKIs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Single-target MET TKIs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Single-target MET TKIs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Single-target MET TKIs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Single-target MET TKIs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Single-target MET TKIs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Single-target MET TKIs Revenue by Region
  1. 7.1 Global Single-target MET TKIs Revenue by Region
  2. 7.1.1 Global Single-target MET TKIs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Single-target MET TKIs Revenue by Region (2021-2026)
  4. 7.1.3 Global Single-target MET TKIs Revenue by Region (2027-2032)
  5. 7.1.4 Global Single-target MET TKIs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Single-target MET TKIs Revenue (2021-2032)
  8. 7.2.2 North America Single-target MET TKIs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Single-target MET TKIs Revenue (2021-2032)
  11. 7.3.2 Europe Single-target MET TKIs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Single-target MET TKIs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Single-target MET TKIs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Single-target MET TKIs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Single-target MET TKIs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CSPC Pharmaceutical
  2. 8.1.1 CSPC Pharmaceutical Company Information
  3. 8.1.2 CSPC Pharmaceutical Business Overview
  4. 8.1.3 CSPC Pharmaceutical Single-target MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CSPC Pharmaceutical Single-target MET TKIs Product Portfolio
  6. 8.1.5 CSPC Pharmaceutical Recent Developments
  7. 8.2 Asymchem
  8. 8.2.1 Asymchem Company Information
  9. 8.2.2 Asymchem Business Overview
  10. 8.2.3 Asymchem Single-target MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Asymchem Single-target MET TKIs Product Portfolio
  12. 8.2.5 Asymchem Recent Developments
  13. 8.3 Shanghai Hutchison Pharmaceuticals
  14. 8.3.1 Shanghai Hutchison Pharmaceuticals Company Information
  15. 8.3.2 Shanghai Hutchison Pharmaceuticals Business Overview
  16. 8.3.3 Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Product Portfolio
  18. 8.3.5 Shanghai Hutchison Pharmaceuticals Recent Developments
  19. 8.4 WuXi STA
  20. 8.4.1 WuXi STA Company Information
  21. 8.4.2 WuXi STA Business Overview
  22. 8.4.3 WuXi STA Single-target MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 WuXi STA Single-target MET TKIs Product Portfolio
  24. 8.4.5 WuXi STA Recent Developments
  25. 8.5 Haihe Biopharma
  26. 8.5.1 Haihe Biopharma Company Information
  27. 8.5.2 Haihe Biopharma Business Overview
  28. 8.5.3 Haihe Biopharma Single-target MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Haihe Biopharma Single-target MET TKIs Product Portfolio
  30. 8.5.5 Haihe Biopharma Recent Developments
  31. 8.6 Avistone Pharmaceuticals Biotechnology
  32. 8.6.1 Avistone Pharmaceuticals Biotechnology Company Information
  33. 8.6.2 Avistone Pharmaceuticals Biotechnology Business Overview
  34. 8.6.3 Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Product Portfolio
  36. 8.6.5 Avistone Pharmaceuticals Biotechnology Recent Developments
  37. 8.7 Novartis
  38. 8.7.1 Novartis Company Information
  39. 8.7.2 Novartis Business Overview
  40. 8.7.3 Novartis Single-target MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Novartis Single-target MET TKIs Product Portfolio
  42. 8.7.5 Novartis Recent Developments
  43. 8.8 Merck
  44. 8.8.1 Merck Company Information
  45. 8.8.2 Merck Business Overview
  46. 8.8.3 Merck Single-target MET TKIs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merck Single-target MET TKIs Product Portfolio
  48. 8.8.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Single-target MET TKIs Value Chain Analysis
  2. 9.1.1 Single-target MET TKIs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Single-target MET TKIs Production Mode & Process
  6. 9.2 Single-target MET TKIs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Single-target MET TKIs Distributors
  9. 9.2.3 Single-target MET TKIs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst